Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Marty

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Expert Review of Hematology|May 17, 2019
The role of the thrombopoietin receptor MPL in myeloproliferative neoplasms: recent findings and potential therapeutic applicationsWilliam Vainchenker, Isabelle Plo, Caroline Marty, et al.
Bone|September 1, 2004
Severe osteopenia in CFTR-null miceFariel Dif, Caroline Marty, Claude Baudoin, et al.
The American Journal of Pathology|April 26, 2007
Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivoDidier Merciris, Caroline Marty, Corinne Collet, et al.
American Journal of Nephrology|September 10, 2020
Cortical Bone Microarchitecture in Dialysis PatientsEva Benillouche, Agnes Ostertag, Caroline Marty, et al.
Frontiers in Endocrinology|October 6, 2017
Identification of <i>MPL</i> R102P Mutation in Hereditary ThrombocytosisChristine Bellanné-Chantelot, Matthieu Mosca, Caroline Marty, et al.
The American Journal of Pathology|March 28, 2012
The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formationCarole Le Henaff, Annelise Gimenez, Eric Haÿ, et al.
Frontiers in Endocrinology|September 29, 2017
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting MegakaryopoiesisIsabelle Plo, Christine Bellanné-Chantelot, Matthieu Mosca, et al.
F1000Research|February 6, 2018
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disordersWilliam Vainchenker, Emilie Leroy, Laure Gilles, et al.
Faculty Reviews|September 29, 2023
Recent advances in therapies for primary myelofibrosisWilliam Vainchenker, Nasrine Yahmi, Violaine Havelange, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 12, 2012
Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formationEric Haÿ, Thibault Buczkowski, Caroline Marty, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Expert Review of Hematology|May 17, 2019
The role of the thrombopoietin receptor MPL in myeloproliferative neoplasms: recent findings and potential therapeutic applicationsWilliam Vainchenker, Isabelle Plo, Caroline Marty, et al.
Bone|September 1, 2004
Severe osteopenia in CFTR-null miceFariel Dif, Caroline Marty, Claude Baudoin, et al.
The American Journal of Pathology|April 26, 2007
Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivoDidier Merciris, Caroline Marty, Corinne Collet, et al.
American Journal of Nephrology|September 10, 2020
Cortical Bone Microarchitecture in Dialysis PatientsEva Benillouche, Agnes Ostertag, Caroline Marty, et al.
Frontiers in Endocrinology|October 6, 2017
Identification of <i>MPL</i> R102P Mutation in Hereditary ThrombocytosisChristine Bellanné-Chantelot, Matthieu Mosca, Caroline Marty, et al.
The American Journal of Pathology|March 28, 2012
The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formationCarole Le Henaff, Annelise Gimenez, Eric Haÿ, et al.
Frontiers in Endocrinology|September 29, 2017
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting MegakaryopoiesisIsabelle Plo, Christine Bellanné-Chantelot, Matthieu Mosca, et al.
F1000Research|February 6, 2018
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disordersWilliam Vainchenker, Emilie Leroy, Laure Gilles, et al.
Faculty Reviews|September 29, 2023
Recent advances in therapies for primary myelofibrosisWilliam Vainchenker, Nasrine Yahmi, Violaine Havelange, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 12, 2012
Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formationEric Haÿ, Thibault Buczkowski, Caroline Marty, et al.
Pageof 10